These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20160487)

  • 41. Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer.
    Kurahara H; Takao S; Maemura K; Mataki Y; Kuwahata T; Maeda K; Ding Q; Sakoda M; Iino S; Ishigami S; Ueno S; Shinchi H; Natsugoe S
    J Surg Oncol; 2012 Jun; 105(7):655-61. PubMed ID: 22213144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential role of regulator of G-protein signaling 16 in cell motility mediated by δEF1 family proteins.
    Hoshi Y; Endo K; Shirakihara T; Fukagawa A; Miyazawa K; Saitoh M
    FEBS Lett; 2016 Jan; 590(2):270-8. PubMed ID: 26823172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
    Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
    Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.
    Suh Y; Yoon CH; Kim RK; Lim EJ; Oh YS; Hwang SG; An S; Yoon G; Gye MC; Yi JM; Kim MJ; Lee SJ
    Oncogene; 2013 Oct; 32(41):4873-82. PubMed ID: 23160379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mechanism of epithelial-to-mesenchymal transition and the relationship with tumor metastasis].
    Ma YH; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):715-7. PubMed ID: 20078984
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
    Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
    Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
    Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
    Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell lines.
    Okajima M; Kokura S; Ishikawa T; Mizushima K; Tsuchiya R; Matsuyama T; Adachi S; Okayama T; Sakamoto N; Kamada K; Katada K; Uchiyama K; Handa O; Takagi T; Yagi N; Naito Y; Yoshikawa T
    Oncol Rep; 2013 Jun; 29(6):2311-7. PubMed ID: 23589103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Yan Q; Wang Z
    Oncol Rep; 2014 Oct; 32(4):1451-8. PubMed ID: 25070659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
    Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
    Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Forkhead factors regulate epithelial plasticity: impact on cancer progression.
    Feuerborn A; Küffer S; Gröne HJ
    Cell Cycle; 2011 Aug; 10(15):2454-60. PubMed ID: 21685726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of MEOX1 in non-neoplastic and neoplastic diseases.
    Zeng G; Liu X; Su X; Wang Y; Liu B; Zhou H; Wang Y; Li F
    Biomed Pharmacother; 2023 Feb; 158():114068. PubMed ID: 36495659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanisms of epithelial-mesenchymal transition.
    Lamouille S; Xu J; Derynck R
    Nat Rev Mol Cell Biol; 2014 Mar; 15(3):178-96. PubMed ID: 24556840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.
    Hill L; Browne G; Tulchinsky E
    Int J Cancer; 2013 Feb; 132(4):745-54. PubMed ID: 22753312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?
    Brabletz S; Brabletz T
    EMBO Rep; 2010 Sep; 11(9):670-7. PubMed ID: 20706219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
    Caramel J; Papadogeorgakis E; Hill L; Browne GJ; Richard G; Wierinckx A; Saldanha G; Osborne J; Hutchinson P; Tse G; Lachuer J; Puisieux A; Pringle JH; Ansieau S; Tulchinsky E
    Cancer Cell; 2013 Oct; 24(4):466-80. PubMed ID: 24075834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.
    Martínez-Campa C; Álvarez-García V; Alonso-González C; González A; Cos S
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of ZEB1 and YAP1 is related to poor prognosis in patients with gliomas with different IDH1 status.
    Miao N; Wang ZQ; Zhang N; Ma ZP; Su LP; Zhai YY; Hu YR; Sang W; Zhang W
    Int J Clin Exp Pathol; 2023; 16(7):138-149. PubMed ID: 37559682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.